[1]
“Roundtable discussion: Navigating challenging treatment decisions in relapsed and refractory multiple myeloma (RRMM)”, Can Hematol Today, vol. 2, no. s07, pp. 2–5, Jul. 2023, doi: 10.58931/cht.2023.2s0736.